ArticleBMC infectious diseases2026
Descriptive epidemiology of opportunistic infections among patients with advanced HIV disease in Kinshasa, Democratic Republic of Congo.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlthough people living with HIV (PLHIV) increasingly have access to antiretroviral therapy (ART) worldwide, the recurrence of advanced HIV disease (AHD) remains a major concern, exposing them to an enhanced risk of opportunistic infections (OIs) and subsequent death. We aimed here to describe the epidemiology of OIs among patients with AHD in Kinshasa (Democratic Republic of Congo, DRC) to inform future actions against AHD-related deaths.
methodsA retrospective cohort study was conducted among consecutive AHD patients admitted to Biyela Hospital Center in Kinshasa (DRC)—a peripheral clinic supported by Médecins Sans Frontières (MSF)-Belgium, between June 2021 and December 2023. The diagnosis of OIs was mainly based on MSF’s advanced HIV management guidelines, establishing the diagnosis of tuberculosis using Determine TB-LAM Ag test and/or Xpert MTB/RIF, cryptococcal meningitis using the CrAg LFA antigen test, and malaria and syphilis using the corresponding Rapid diagnostic tests. For other OIs such as cerebral toxoplasmosis, oropharyngeal candidiasis, Pneumocystis jirovecii pneumonia, and nonspecific bacterial infections, diagnosis was essentially based on the clinician’s clinical presumption, due to resource limitations. Descriptive statistics were performed using SPSS version 27.00.
resultsAmong the 130 included AHD patients (58.8% female, mean age 42 ± 16 years), 59.2% presented with multiple OIs. The most prevalent OIs were meningeal tuberculosis (61.5%), cerebral toxoplasmosis (51.5%), nonspecific bacterial pneumonia (33.1%), pulmonary tuberculosis (32.2%), cryptococcal meningitis (20.0%), nonspecific bacterial meningitis (18.5%), oropharyngeal candidiasis (17.7%), and cerebral malaria (10.8%). The clinical presentation of meningeal tuberculosis, cerebral toxoplasmosis, nonspecific bacterial pneumonia, nonspecific bacterial meningitis, and pulmonary tuberculosis was mainly characterized by fever (75%, 72.7%, 79.1%, 75%, 67.5%, respectively); cryptococcal meningitis by incoherent speech (77.7%); and oropharyngeal candidiasis by weight loss (68.2%).
conclusionsPatients with AHD in Kinshasa (DRC) frequently experience multiple OIs. While the majority of these OIs are commonly recognized in the end-stage of HIV infection (tuberculosis, cerebral toxoplasmosis, cryptococcal meningitis, nonspecific bacterial infections, oropharyngeal candidiasis), cerebral malaria is another condition that should be considered in the DRC context.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.